EGFR and breast carcinoma: These included olfactory transduction, primary immunodeficiency, PI3K-AKT signaling, tyrosine metabolism, chemokine signaling, JAK-STAT signaling, basal cell carcinoma, T-cell receptor signaling, Wnt signaling, EGFR tyrosine inhibitor resistance, RAS signaling, and breast cancer signaling.